GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On this platform, MVA, a large virus capable of carrying several vaccine antigens, expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host similar to a live-attenuated virus, while providing the safety characteristics of a replication-defective vector.
Company profile
Ticker
GOVX, GOVXW
Exchange
Website
CEO
David Dodd
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Geovax Labs, Inc., DAUPHIN TECHNOLOGY INC, SUCCESSO INC
SEC CIK
Corporate docs
Subsidiaries
GeoVax, Inc. • Immutak Oncology, Inc. ...
IRS number
870455038
GOVX stock data
News
Traders Circulate NYT Article Titled 'Will There Be Enough Monkeypox Vaccine?'
1 Jul 22
'State health officials said Friday they've identified the first confirmed case of monkeypox in Wisconsin.' - News 3 Now
1 Jul 22
Orange County, California Health Care Agency Confirmed the First Presumptive Case of Monkeypox in the County on Thursday
30 Jun 22
'As of today, 78 people have tested positive for orthopoxvirus in NYC, which is presumed to be monkeypox.' - nychealth
30 Jun 22
'Cleveland Health Department now announcing the first case of the monkey pox virus in the City—health department says this "does not currently present a risk to the general public"' - Tweet By Ed Gallek
30 Jun 22
Press releases
Thinking about buying stock in Li Auto, F-Star Therapeutics, Geovax Labs, Accelerate Diagnostics, or Funko?
23 Jun 22
Thinking about buying stock in Canopy Growth, Gap, Geovax Labs, Redbox Entertainment, or Plug Power?
27 May 22
Thinking about buying stock in Geovax Labs, Concert Pharmaceuticals, Redbox Entertainment, Blacksky Technology, or Big Lots?
26 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
25 May 22
Thinking about buying stock in Geovax Labs, Genocea Biosciences, Motus GI, Express, or Caleres?
25 May 22
Investment data
Securities sold
Number of investors
Calendar
27 Apr 22
2 Jul 22
31 Dec 22
Financial summary
| Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 16.26M | 16.26M | 16.26M | 16.26M | 16.26M | 16.26M |
| Cash burn (monthly) | (no burn) | 382.09K | 809.35K | 1.63M | 1.44M | 1.16M |
| Cash used (since last report) | n/a | 1.17M | 2.48M | 5.01M | 4.43M | 3.56M |
| Cash remaining | n/a | 15.09M | 13.78M | 11.25M | 11.83M | 12.7M |
| Runway (months of cash) | n/a | 39.5 | 17.0 | 6.9 | 8.2 | 11.0 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jun 22 | Kelly T. Jr. McKee | Common Stock | Buy | Acquire P | No | No | 1.12 | 4,464 | 5K | 19,185 |
| 21 Jun 22 | Randal D Chase | Common Stock | Buy | Acquire P | No | No | 1.21 | 10,000 | 12.1K | 26,613 |
| 5 May 22 | Kelly T. Jr. McKee | Common Stock | Buy | Acquire P | No | No | 0.72 | 9,722 | 7K | 14,721 |
| 4 May 22 | Kelly T. Jr. McKee | Common Stock | Buy | Acquire P | No | No | 0.71 | 4,999 | 3.55K | 4,999 |
Institutional ownership, Q1 2022
10.5% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 17 |
| Opened positions | 6 |
| Closed positions | 5 |
| Increased positions | 2 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 2.61M |
| Total shares | 1.32M |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Armistice Capital | 435.15K | $500K |
| Vanguard | 258.77K | $298K |
| Cavalry Fund I Management | 219.34K | $1.01M |
| Bigger Capital Fund L P | 151.12K | $511K |
| Geode Capital Management | 52.82K | $60K |
| VIRT Virtu Financial | 49.68K | $57K |
| Two Sigma Investments | 27.32K | $31K |
| Dimensional Fund Advisors | 24.06K | $28K |
| STT State Street | 22.14K | $25K |
| Welch & Forbes | 16.99K | $20K |
Financial report summary
?Competition
Bristol-Myers Squibb • Pfizer • Astrazeneca • Novavax • Advaxis • Sanofi • Lumos Pharma • GSK • Tonix Pharmaceuticals Holding • Chinook TherapeuticsContent analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
agent, Alabama, antidilutive, assessment, Birmingham, booster, comprehensive, discovered, HHS, IND, individual, interpretation, Moderna, mRNA, nominal, placement, prorated, review, royalty, Southern, subsequent, transaction, vest, vesting
Removed:
adding, Additionally, AGT, Aid, American, animal, April, array, assemble, Australia, awarded, backed, bank, boost, California, capable, collaboration, collaborative, combinational, commence, consist, consistent, consortium, conversion, convertible, deficiency, derived, detail, directly, disease, durable, economic, elicit, enacted, Europe, evaluate, financially, focused, forgiven, franchise, Francisco, gene, HIV, host, HVTN, immune, Immunodeficiency, immunogenicity, incurring, induce, insurance, International, investment, issuable, Japan, large, led, lender, loan, managed, MVA, Nasdaq, negligible, Network, part, particle, Paycheck, percent, person, platform, PPP, preferred, prevalent, prevention, progressing, Promissory, Protection, protein, registration, Relief, remain, remission, restated, resulting, retroactive, retroactively, reverse, San, Senior, September, Small, stimulating, subtype, successfully, supported, target, tumor, UCSF, underwriter, underwriting, underwritten, upcoming, vaccinated, Vaccinia, validating, VLP, Western
Financial reports
Current reports
8-K
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
27 May 22
8-K
GeoVax Reports 2022 First Quarter Financial Results
2 May 22
8-K
GeoVax Reports 2021 Year-End Financial Results
10 Mar 22
8-K
GeoVax Announces $10 Million Private Placement
20 Jan 22
8-K
GeoVax Issues Shareholder Update Letter
4 Jan 22
8-K
GeoVax Announces Initiation of Phase 2 Clinical Trial
15 Dec 21
8-K
GeoVax Reports 2021 Third Quarter Financial Results
12 Nov 21
8-K
GeoVax and City of Hope Announce Agreement to
10 Nov 21
8-K
GeoVax Gedeptin License Announcement Call
30 Sep 21
8-K
Entry into a Material Definitive Agreement
29 Sep 21
Registration and prospectus
424B3
Prospectus supplement
27 Jun 22
D
$15M in equity / options, sold $15M, 1 investor
22 Jun 22
424B5
Prospectus supplement for primary offering
27 May 22
424B3
Prospectus supplement
27 Apr 22
424B3
Prospectus supplement
27 Apr 22
POS AM
2021 FY
Prospectus update (post-effective amendment)
9 Mar 22
POS AM
2021 FY
Prospectus update (post-effective amendment)
9 Mar 22
424B3
Prospectus supplement
11 Feb 22
S-1
2021 Q3
IPO registration
4 Feb 22
Other
EFFECT
Notice of effectiveness
27 Jun 22
EFFECT
Notice of effectiveness
11 Mar 22
EFFECT
Notice of effectiveness
11 Mar 22
EFFECT
Notice of effectiveness
11 Feb 22
CORRESP
Correspondence with SEC
7 Feb 22
UPLOAD
Letter from SEC
6 Feb 22
EFFECT
Notice of effectiveness
25 Mar 21
EFFECT
Notice of effectiveness
4 Feb 21
CORRESP
Correspondence with SEC
31 Jan 21
UPLOAD
Letter from SEC
31 Jan 21
Ownership
4
GeoVax Labs / Kelly T. Jr. McKee ownership change
28 Jun 22
4
GeoVax Labs / RANDAL D CHASE ownership change
22 Jun 22
3
GeoVax Labs / John W. Sharkey ownership change
22 Jun 22
4
GeoVax Labs / Kelly T. Jr. McKee ownership change
6 May 22
4
GeoVax Labs / Kelly T. Jr. McKee ownership change
4 May 22
SC 13G/A
GeoVax Labs / L1 Capital Global Opportunities Master Fund ownership change
13 Feb 22
3
GeoVax Labs / Kelly T. Jr. McKee ownership change
11 Jan 22
SC 13G/A
GeoVax Labs / SABBY MANAGEMENT ownership change
4 Jan 22
4
GeoVax Labs / JOHN N SPENCER JR ownership change
8 Dec 21
4
GeoVax Labs / ROBERT T MCNALLY ownership change
8 Dec 21
Transcripts
2022 Q1
Earnings call transcript
28 Apr 22
2021 Q4
Earnings call transcript
10 Mar 22
2021 Q3
Earnings call transcript
12 Nov 21
2021 Q2
Earnings call transcript
12 Aug 21
2021 Q1
Earnings call transcript
9 May 21
2020 Q4
Earnings call transcript
24 Mar 21
2020 Q3
Earnings call transcript
8 Nov 20
2020 Q3
Earnings call transcript
6 Nov 20
Reddit threads
I was going through some old folders and found this threatening letter my dad sent to his broker back in 2000
15 Jun 22
The WSB Trash Bin, Discussion Thread for the Week of June 10, 2022
10 Jun 22
The Monkeypox Penny Stock - $GOVX. Strong technical breakout.
6 Jun 22
r/Stocks Daily Discussion & Fundamentals Friday May 27, 2022
27 May 22
Daily Plays May 27, 2022
27 May 22
💰Good morning! #premarket #watchlist 05/26 $HAPP -old news, $TCBP -potential shares secondary offering, $M -First Quarter Results , $AVDL -old news, $BBIG -Delays Cryptyde Spin-off Distribution Date , $GNCA -old news about shutdown, $GOVX -shares offering. Check it all in Realtime Stock Screener!
26 May 22
💰Good morning! #premarket #watchlist 05/26 $VGFC -old news, $TCBP -potential shares secondary offering, $M -First Quarter Results , $DKS -First Quarter Results, $JOBY -potential shares offering, $GNCA -old news about shutdown, $GOVX -shares offering.
26 May 22
💰Good morning! #premarket #watchlist 05/26 $VGFC -old news, $TCBP -potential shares secondary offering, $M -First Quarter Results , $DKS -First Quarter Results, $JOBY -potential shares offering, $GNCA -old news about shutdown, $GOVX -shares offering.
26 May 22
💰Good morning! #premarket #watchlist 05/26 $VGFC -old news, $TCBP -potential shares secondary offering, $M -First Quarter Results , $DKS -First Quarter Results, $JOBY -potential shares offering, $GNCA -old news about shutdown, $GOVX -shares offering.
26 May 22
Daily Plays May 26, 2022
26 May 22